Skip survey header

Type 2B VWD During Pregnancy and Postpartum Guidance - Public Comment

Management of Women with Type 2B von Willebrand Disease During Pregnancy and Postpartum: Guidance from ISTH SSC Subcommittees on von Willebrand Factor and Women’s Health Issues in Thrombosis and Haemostasis: Open for public review

The ISTH has recently drafted a guidance manuscript on the clinical care of women with type 2B von Willebrand disease during pregnancy and postpartum, given the accumulating evidence from a comprehensive literature review. The guidance was developed by a panel of 8 content experts.

The draft guidance is available for review HERENote: This manuscript is confidential and in draft form.

We now kindly ask the greater community of physicians, scientists, and allied health professionals to review and provide any comments by June 30, 2025.
1. Please enter your information, due to conflict of interest concerns, anonymous comments will not be accepted.
Comments will not be attributed, published or provided to anyone beyond the Guideline and Guidance Committee. 
This question requires a valid email address.
Click the submit button below to send your comments. If you would like to make additional comments, you may submit additional forms.